Travere Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2011 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Travere Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2011 to Q3 2024.
  • Travere Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 77.9M shares, a 3.72% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 77.9M +2.8M +3.72% Sep 30, 2024 10-Q 2024-10-31
Q2 2024 76.5M +1.48M +1.98% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 76.1M +1.52M +2.04% Mar 31, 2024 10-Q 2024-05-06
Q4 2023 75.4M +11.1M +17.2% Dec 31, 2023 10-Q 2024-10-31
Q3 2023 75.1M +11M +17.1% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 75M +11.1M +17.4% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 74.6M +11.1M +17.4% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 64.3M +1.8M +2.88% Dec 31, 2022 10-K 2024-02-20
Q3 2022 64.2M +3.13M +5.13% Sep 30, 2022 10-Q 2022-10-27
Q2 2022 63.8M +3.13M +5.15% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 63.5M +3.07M +5.09% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 62.5M +10.2M +19.6% Dec 31, 2021 10-K 2023-02-23
Q3 2021 61M +10M +19.6% Sep 30, 2021 10-Q 2021-10-29
Q2 2021 60.7M +9.81M +19.3% Jun 30, 2021 10-Q 2021-07-29
Q1 2021 60.4M +17.3M +40% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 52.2M +9.16M +21.3% Dec 31, 2020 10-K 2022-02-24
Q3 2020 51M +8.06M +18.8% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 50.9M +8M +18.7% Jun 30, 2020 10-Q 2020-07-31
Q1 2020 43.2M +1.72M +4.14% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 43.1M +1.7M +4.11% Dec 31, 2019 10-K 2021-03-01
Q3 2019 43M +1.79M +4.35% Sep 30, 2019 10-Q 2019-10-30
Q2 2019 42.9M +2.53M +6.26% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 41.4M +1.56M +3.92% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 41.4M +2.02M +5.12% Dec 31, 2018 10-K 2020-02-24
Q3 2018 41.2M +1.89M +4.8% Sep 30, 2018 10-Q 2018-11-01
Q2 2018 40.4M +2.08M +5.43% Jun 30, 2018 10-Q 2018-08-03
Q1 2018 39.9M +1.71M +4.49% Mar 31, 2018 10-Q/A 2018-07-06
Q4 2017 39.4M +1.47M +3.87% Dec 31, 2017 10-K 2019-02-26
Q3 2017 39.3M +1.58M +4.18% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 38.3M +1.57M +4.26% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 38.2M +1.57M +4.29% Mar 31, 2017 10-Q 2017-05-05
Q4 2016 37.9M +1.44M +3.95% Dec 31, 2016 10-K/A 2018-07-06
Q3 2016 37.7M +1.7M +4.71% Sep 30, 2016 10-Q 2016-11-04
Q2 2016 36.7M +1.65M +4.71% Jun 30, 2016 10-Q 2016-08-05
Q1 2016 36.6M +1.75M +5.01% Mar 31, 2016 10-Q 2016-05-05
Q4 2015 36.5M +10.4M +40% Dec 31, 2015 10-K 2017-03-01
Q3 2015 36M +9.69M +36.8% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 35.1M +8.77M +33.3% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 34.8M +10.4M +42.7% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 26M +7.63M +41.4% Dec 31, 2014 10-K 2016-02-26
Q3 2014 26.3M +7.94M +43.2% Sep 30, 2014 10-Q 2014-11-13
Q2 2014 26.3M +14M +113% Jun 30, 2014 10-Q 2014-08-14
Q1 2014 24.4M +12.2M +100% Mar 31, 2014 10-Q 2014-05-15
Q4 2013 18.4M +9.46M +106% Dec 31, 2013 10-K/A 2015-07-09
Q3 2013 18.4M Sep 30, 2013 10-Q/A 2015-07-09
Q2 2013 12.3M Jun 30, 2013 10-Q 2013-09-16
Q1 2013 12.2M +12.1M +11326% Mar 31, 2013 10-Q/A 2013-09-16
Q4 2012 8.95M +4.91M +121% Dec 31, 2012 10-K/A 2015-07-09
Q1 2012 107K Feb 29, 2012 10-Q 2013-03-06
Q4 2011 4.04M Dec 31, 2011 10-K/A 2013-09-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.